CPTR — Captor Capital Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual cashflow statement for Captor Capital, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3.78 | -46.4 | -32.9 | -6.99 | -18.4 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -4.97 | 33.2 | 21.4 | 0.832 | 11.7 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.15 | 4.85 | -0.811 | 2.34 | -3.03 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Cash from Operating Activities | -2.34 | -8.09 | -11.8 | -2.79 | -6.64 |
Capital Expenditures | — | -0.214 | -0.363 | -1.63 | -1.18 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -36.4 | 19.6 | 0.608 | 4.54 | 0.575 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -36.4 | 19.4 | 0.245 | 2.91 | -0.604 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 60 | 0.035 | -1.63 | -1.65 | 10.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 21.3 | 11.4 | -13 | -2.4 | 2.95 |